222 related articles for article (PubMed ID: 32808708)
1. lncRNA CERS6-AS1 as ceRNA promote cell proliferation of breast cancer by sponging miR-125a-5p to upregulate BAP1 expression.
Yan L; Li K; Feng Z; Zhang Y; Han R; Ma J; Zhang J; Wu X; Liu H; Jiang Y; Zhang Y; Zhu Y
Mol Carcinog; 2020 Oct; 59(10):1199-1208. PubMed ID: 32808708
[TBL] [Abstract][Full Text] [Related]
2. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
Pan W; Chen KJ; Huang YC
Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
[TBL] [Abstract][Full Text] [Related]
3. MiR-125a-5p functions as a tumour suppressor in breast cancer by downregulating BAP1.
Yan L; Yu MC; Gao GL; Liang HW; Zhou XY; Zhu ZT; Zhang CY; Wang YB; Chen X
J Cell Biochem; 2018 Nov; 119(11):8773-8783. PubMed ID: 30076753
[TBL] [Abstract][Full Text] [Related]
4. CERS6-AS1 contributes to the malignant phenotypes of colorectal cancer cells by interacting with miR-15b-5p to regulate SPTBN2.
Zhao SY; Wang Z; Wu XB; Zhang S; Chen Q; Wang DD; Tan QF
Kaohsiung J Med Sci; 2022 May; 38(5):403-414. PubMed ID: 35146902
[TBL] [Abstract][Full Text] [Related]
5. LncRNA CERS6-AS1 Is a Tumor Promoter in Cervical Cancer by Sponging miR-195-5p.
Xiong S; Song H
Ann Clin Lab Sci; 2023 Jan; 53(1):30-41. PubMed ID: 36889776
[TBL] [Abstract][Full Text] [Related]
6. LncRNA CERS6-AS1, sponging miR-6838-5p, promotes proliferation and invasion in cervical carcinoma cells by upregulating FOXP2.
Yan K; Hu C; Liu C; Chu G; Wang X; Ma S; Li L
Histol Histopathol; 2023 Jul; 38(7):823-835. PubMed ID: 36444938
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long noncoding RNA TP73-AS1 suppresses the malignant progression of breast cancer cells in vitro through targeting miRNA-125a-3p/metadherin axis.
Liu Y; Wei G; Ma Q; Han Y
Thorac Cancer; 2020 Feb; 11(2):394-407. PubMed ID: 31901156
[TBL] [Abstract][Full Text] [Related]
8. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
Gao KF; Zhao YF; Liao WJ; Xu GL; Zhang JD
Kaohsiung J Med Sci; 2022 Jun; 38(6):542-553. PubMed ID: 35199935
[TBL] [Abstract][Full Text] [Related]
9. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
Liang WH; Li N; Yuan ZQ; Qian XL; Wang ZH
Mol Carcinog; 2019 Apr; 58(4):461-473. PubMed ID: 30457164
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA CERS6-AS1 functions as a malignancy promoter in breast cancer by binding to IGF2BP3 to enhance the stability of CERS6 mRNA.
Bao G; Huang J; Pan W; Li X; Zhou T
Cancer Med; 2020 Jan; 9(1):278-289. PubMed ID: 31701672
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
12. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis.
Yun Z; Meng F; Li S; Zhang P
Aging (Albany NY); 2021 Feb; 13(4):6041-6054. PubMed ID: 33581689
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Modulating HMGA1.
Shen R; Wang X; Wang S; Zhu D; Li M
Pancreas; 2021 Apr; 50(4):617-624. PubMed ID: 33939677
[TBL] [Abstract][Full Text] [Related]
16. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2.
Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y
Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214
[TBL] [Abstract][Full Text] [Related]
17. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
Wu X; Kong C; Wu Y
Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
[TBL] [Abstract][Full Text] [Related]
18. CERS6 antisense RNA 1 promotes colon cancer via upregulating mitochondrial calcium uniporter.
Yu J; Chen X; Li J; Wang F
Eur J Clin Invest; 2023 May; 53(5):e13951. PubMed ID: 36628448
[TBL] [Abstract][Full Text] [Related]
19. LncRNA AFAP1-AS1 Knockdown Represses Cell Proliferation, Migration, and Induced Apoptosis in Breast Cancer by Downregulating
Cai B; Wang X; Bu Q; Li P; Xue Q; Zhang J; Ding P; Sun D
Cancer Biother Radiopharm; 2022 Oct; 37(8):662-672. PubMed ID: 32955920
[No Abstract] [Full Text] [Related]
20. CERS6-AS1 Facilitates Oncogenesis and Restrains Ferroptosis in Papillary Thyroid Carcinoma by Serving as a ceRNA through miR-497-5p/LASP1 Axis.
Huang T; Guan S; Wang C
Ann Clin Lab Sci; 2022 May; 52(3):426-438. PubMed ID: 35777805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
